z-logo
Premium
Using bumetanide to treat autism appears promising but further clinical trials are needed to confirm this approach
Author(s) -
BenAri Yehezkel,
Lemonnier Eric
Publication year - 2021
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/apa.15747
Subject(s) - bumetanide , autism , clinical trial , medicine , intensive care medicine , neuroscience , psychology , psychiatry , chemistry , cotransporter , organic chemistry , sodium

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom